Constantiam Biosciences Inc.
Publicly observedKaty, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Katy | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Constantiam Biosciences Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | PJYLYX1ED6V4 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant24 Sept 2024Publicly observed
NIH SBIR/STTR award: Leveraging high-throughput functional data for assessment of Alzheimer's risk
USD 1,252,240.00 · National Institute on Aging · Source: NIH RePORTER (opens in a new tab)
- Grant23 Jan 2023Publicly observed
NIH SBIR/STTR award: Platform to support clinical variant interpretation through probabilistic assessment of functional evidence
USD 1,030,156.00 · National Human Genome Research Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.